Cargando…
Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
Population-scale expression profiling studies can provide valuable insights into biological and disease-underlying mechanisms. The availability of phenotypic traits is essential for studying clinical effects. Therefore, missing, incomplete, or inaccurate phenotypic information can make analyses chal...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339202/ https://www.ncbi.nlm.nih.gov/pubmed/35907790 http://dx.doi.org/10.1186/s12864-022-08771-7 |
_version_ | 1784760142759198720 |
---|---|
author | Niehues, Anna Bizzarri, Daniele Reinders, Marcel J.T. Slagboom, P. Eline van Gool, Alain J. van den Akker, Erik B. ’t Hoen, Peter A.C. |
author_facet | Niehues, Anna Bizzarri, Daniele Reinders, Marcel J.T. Slagboom, P. Eline van Gool, Alain J. van den Akker, Erik B. ’t Hoen, Peter A.C. |
author_sort | Niehues, Anna |
collection | PubMed |
description | Population-scale expression profiling studies can provide valuable insights into biological and disease-underlying mechanisms. The availability of phenotypic traits is essential for studying clinical effects. Therefore, missing, incomplete, or inaccurate phenotypic information can make analyses challenging and prevent RNA-seq or other omics data to be reused. A possible solution are predictors that infer clinical or behavioral phenotypic traits from molecular data. While such predictors have been developed based on different omics data types and are being applied in various studies, metabolomics-based surrogates are less commonly used than predictors based on DNA methylation profiles.In this study, we inferred 17 traits, including diabetes status and exposure to lipid medication, using previously trained metabolomic predictors. We evaluated whether these metabolomic surrogates can be used as an alternative to reported information for studying the respective phenotypes using expression profiling data of four population cohorts. For the majority of the 17 traits, the metabolomic surrogates performed similarly to the reported phenotypes in terms of effect sizes, number of significant associations, replication rates, and significantly enriched pathways.The application of metabolomics-derived surrogate outcomes opens new possibilities for reuse of multi-omics data sets. In studies where availability of clinical metadata is limited, missing or incomplete information can be complemented by these surrogates, thereby increasing the size of available data sets. Additionally, the availability of such surrogates could be used to correct for potential biological confounding. In the future, it would be interesting to further investigate the use of molecular predictors across different omics types and cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12864-022-08771-7). |
format | Online Article Text |
id | pubmed-9339202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93392022022-08-01 Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies Niehues, Anna Bizzarri, Daniele Reinders, Marcel J.T. Slagboom, P. Eline van Gool, Alain J. van den Akker, Erik B. ’t Hoen, Peter A.C. BMC Genomics Research Population-scale expression profiling studies can provide valuable insights into biological and disease-underlying mechanisms. The availability of phenotypic traits is essential for studying clinical effects. Therefore, missing, incomplete, or inaccurate phenotypic information can make analyses challenging and prevent RNA-seq or other omics data to be reused. A possible solution are predictors that infer clinical or behavioral phenotypic traits from molecular data. While such predictors have been developed based on different omics data types and are being applied in various studies, metabolomics-based surrogates are less commonly used than predictors based on DNA methylation profiles.In this study, we inferred 17 traits, including diabetes status and exposure to lipid medication, using previously trained metabolomic predictors. We evaluated whether these metabolomic surrogates can be used as an alternative to reported information for studying the respective phenotypes using expression profiling data of four population cohorts. For the majority of the 17 traits, the metabolomic surrogates performed similarly to the reported phenotypes in terms of effect sizes, number of significant associations, replication rates, and significantly enriched pathways.The application of metabolomics-derived surrogate outcomes opens new possibilities for reuse of multi-omics data sets. In studies where availability of clinical metadata is limited, missing or incomplete information can be complemented by these surrogates, thereby increasing the size of available data sets. Additionally, the availability of such surrogates could be used to correct for potential biological confounding. In the future, it would be interesting to further investigate the use of molecular predictors across different omics types and cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12864-022-08771-7). BioMed Central 2022-07-31 /pmc/articles/PMC9339202/ /pubmed/35907790 http://dx.doi.org/10.1186/s12864-022-08771-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Niehues, Anna Bizzarri, Daniele Reinders, Marcel J.T. Slagboom, P. Eline van Gool, Alain J. van den Akker, Erik B. ’t Hoen, Peter A.C. Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
title | Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
title_full | Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
title_fullStr | Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
title_full_unstemmed | Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
title_short | Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
title_sort | metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339202/ https://www.ncbi.nlm.nih.gov/pubmed/35907790 http://dx.doi.org/10.1186/s12864-022-08771-7 |
work_keys_str_mv | AT niehuesanna metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT bizzarridaniele metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT reindersmarceljt metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT slagboompeline metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT vangoolalainj metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT vandenakkererikb metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies AT thoenpeterac metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies |